NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market on Thursday that its revenues for the fiscal third quarter rose 7 percent year over year.

During the three months ended July 31, total revenues increased to $1.77 billion from $1.65 billion in the year-ago period, surpassing the average analyst estimate of $1.75 billion.

Orders in the quarter were $1.74 billion, a 9 percent increase from $1.60 billion a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.